Abacavir
- Product NDC
- 67046-1602
- 11-digit product format
- 670461602
- Labeler code
- 67046
- Product ID
- 67046-1602_48c0d443-a111-0039-e063-6394a90a9076
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abacavir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Coupler LLC
- Application
- ANDA091560
- Marketing category
- ANDA
- Marketing start
- 2021-04-01
- Substance
- ABACAVIR SULFATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cytochrome P450 1A1 Inhibitors [MoA], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Abacavir
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ABACAVIR SULFATE | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | J220T4J9Q2 |
| Rxcui | 242679 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67046-1602-3 | Abacavir | 30 in 1 BLISTER PACK | TABLET | 30 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 67046-1602-3 | 67046160203 | 30 TABLET in 1 BLISTER PACK (67046-1602-3) | 30 tablet | 2021-04-01 | No | No | Historical |